Concord Biotech Ltd

NSE: CONCORDBIO · BSE: 543960 · Pharmaceuticals & Biotechnology · 27 announcements

Share price: ₹1,368.80
Market cap: ₹14,320 Cr
Revenue (annual): ₹1,055 Cr
Net profit (annual): ₹260.9 Cr
P/E (TTM): 52.0×Sector 47.4×
Promoter holding: 44.08%+0.00% QoQ
FII holding: 7.53%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Regulatory Approval 3 Other Announcement 3 Financial Results 3 Board Meeting Date 3 Business Update 2 Bonus Issue 2 Annual General Meeting 2 Management Change 1 Legal & Regulatory 1 Dividend 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

29 May 2026 19:22 IST NSE

Management Change

Concord Biotech Management Change

Concord Biotech appointed Mrs. Ekta Sanghi Gupta as Independent Director for a five-year term effective June 2026. The board also re-appointed its internal and cost auditors.

Execution: 60 months

Read the filing ↗